Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhong injection for peri-procedural myocardial protection in high-risk acute myocardial infarction patients undergoing primary PCI
ChiCTR1800019451Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of danhong injection in myocardial infarction (MI) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Infarct size and Myocardial salvage index. Started Jan 2015; status: recruiting.
02
Drugs
danhong injection
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1800019451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019451.